Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Financial Flexibility Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Financial Flexibility Index of 0.62x as of September 2025. Free cash flow of CN¥51.39 Million (operating CF CN¥21.03 Million minus capex CN¥30.36 Million) represents 1% of total liabilities (CN¥82.76 Million). Also explore Shanghai Yizhong Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 8 annual periods. Check Shanghai Yizhong Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Shanghai Yizhong Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Shanghai Yizhong Pharmaceutical Co Ltd (688091) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.78x | CN¥119.47 Million | CN¥39.44 Million | CN¥42.97 Million | ▲ +216.5% |
| 2023 | 0.88x | CN¥95.34 Million | CN¥86.55 Million | CN¥108.52 Million | ▼ -78.8% |
| 2022 | 4.14x | CN¥146.67 Million | CN¥110.78 Million | CN¥35.42 Million | ▲ +327.0% |
| 2021 | -1.82x | CN¥-45.64 Million | CN¥-48.78 Million | CN¥25.02 Million | ▼ -83.6% |
| 2020 | -0.99x | CN¥-15.21 Million | CN¥-20.21 Million | CN¥15.30 Million | ▼ -151.5% |
| 2019 | 1.93x | CN¥23.67 Million | CN¥-23.91 Million | CN¥12.26 Million | ▲ +558.4% |
| 2018 | -0.42x | CN¥-7.22 Million | CN¥-10.68 Million | CN¥17.15 Million | ▲ +34.4% |
| 2017 | -0.64x | CN¥-10.38 Million | CN¥-11.51 Million | CN¥16.17 Million | — |